Abstract
We studied the disposition of chloramphenicol after intravenous administration to 56 infants and children aged one day to 11 years at doses ranging from 12.5 to 100 mg/Kg/day. The mean T 1/2 was 5.94 hrs (range 0.87 - 17.8 hrs); neonates had a longer T 1/2, 8.01 hrs, but not statistically different from non neonates, 5.54 hrs (p = 0.12). The T 1/2 of patients who weighed 10 kg (9.02 vs 4.55 hrs; p < 0.001). In 17 patients the pharmacologic peak concentration (Co) standardized for dose linearly correlated with dosage based on body surface area (r = 0.61) or body weight (r = 0.60). The Co values, however, were highly variable; serum concentrations ranged from 0.39 to 2.43 μg/ml per mg per kg administered (m = 0.97 μg/ml). Eight patients had T 1/2 values which approached infinity; in all eight the concentration of total serum chloramphenicol compounds was greater than biologically active drug during the 8 hour observation period. Four of these 8 patients were hypotensive at the time of the study, but none had laboratory evidence of renal or hepatic failure. One-half of these 8 patients on re-study after clinical improvement had T 1/2 between 4.02 and 20.8 hrs. We conclude that there is a marked individual variation in chloramphenicol pharmacokinetics which is, in part, explicable by delayed hydrolysis of the succinate ester and decreased excretion.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.